Drug Trial Radar · NCT05465681
Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Last checked: Nov 19, 2026Latest source record: Apr 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Aug 30, 2022
Primary completion
Jan 13, 2023
Study completion Jan 13, 2023
Sponsor
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 20, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and pharmacokinetics of single-dose HR20013 for injection combined with dexamethasone in patients with malignant solid tumors receiving cisplatin-based chemotherapy.
Conditions
- Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
Interventions
HR20013 for injection;dexamethasonDrug
HR20013 for injection;Drug for preventing nausea and vomiting caused by chemotherapy. dexamethasone: Drug for preventing nausea and vomiting caused by chemotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUC0-t :area under the plasma concentration-time curve from time 0 to the time of the last quantifiable concentrationTime frame: 0 to 504 hours
- AUC0-∞:Area Under the Plasma Concentration-time Curve From Time 0 to InfinityTime frame: 0 to 504 hours
- Cmax:observed maximum plasma concentrationTime frame: 0 to 504 hours
- Tmax:observed time to reach CmaxTime frame: 0 to 504 hours
- T1/2z:apparent terminal half-lifeTime frame: 0 to 504 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.